
    
      A prospective, double-blinded randomized control trial. Randomly allocated patient undergoing
      posterior lumbar spinal fusion into 3 groups (n=32) to receive Parecoxib, Ketorolac and
      Placebo around 30 minutes prior to incised skin. Efficacy was assessed by visual analog scale
      score (0-10), total opioid consumption, complication and bleeding also recorded.
    
  